$WAT
WATERS CORP /DE/ Stock $wat

$wat Overview Financials Valuation SEC Filings Company Website

2014 Form 10-K Financial Statement

#000119312515067900 Filed on February 27, 2015

Income Statement

Concept	2014	2013 Q4	2013 Q3
Revenue	$1.989B	$565.4M	$457.3M
YoY Change	4.47%	8.37%	1.64%
Cost Of Revenue	$824.9M	$229.0M	$191.6M
YoY Change	5.29%	9.9%	4.85%
Gross Profit	$1.164B	$336.5M	$265.7M
YoY Change	3.9%	7.36%	-0.56%
Gross Profit Margin	58.53%	59.5%	58.11%
Selling, General & Admin	$512.7M	$130.7M	$120.6M
YoY Change	4.0%	6.99%	4.54%
% of Gross Profit	44.03%	38.84%	45.37%
Research & Development	$107.7M	$26.98M	$23.60M
YoY Change	7.15%	8.08%	-0.66%
% of Gross Profit	9.25%	8.02%	8.88%
Depreciation & Amortization	$46.39M	$21.50M	$20.50M
YoY Change	21.56%	22.16%	-0.49%
% of Gross Profit	3.98%	6.39%	7.71%
Operating Expenses	$620.4M	$157.7M	$144.2M
YoY Change	4.54%	7.17%	3.66%
Operating Profit	$517.9M	$176.2M	$119.1M
YoY Change	0.11%	10.52%	-2.2%
Interest Expense	$34.19M	$7.927M	$7.358M
YoY Change	13.78%	4.34%	3.53%
% of Operating Profit	6.6%	4.5%	6.18%
Other Income/Expense, Net	$0.00	$0.00
YoY Change	-100.0%
Pretax Income	$490.7M	$169.3M	$112.7M
YoY Change	0.13%	10.65%	-2.73%
Income Tax	$59.12M	$27.74M	$14.61M
% Of Pretax Income	12.05%	16.38%	12.97%
Net Earnings	$431.6M	$141.6M	$98.00M
YoY Change	-4.09%	-19.5%	-1.11%
Net Earnings / Revenue	21.7%	25.04%	21.43%
Basic Earnings Per Share	$5.12
Diluted Earnings Per Share	$5.07	$1.647M	$1.134M
COMMON SHARES
Basic Shares Outstanding	84.36M shares	85.01M shares	85.19M shares
Diluted Shares Outstanding	85.15M shares	86.02M shares	86.36M shares

Balance Sheet

Concept	2014	2013 Q4	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.055B	$1.804B	$1.699B
YoY Change	13.95%	17.2%	17.31%
Cash & Equivalents	$422.2M	$440.8M	$431.0M
Short-Term Investments	$1.633B	$1.363B	$1.268B
Other Short-Term Assets	$81.60M	$78.80M	$99.20M
YoY Change	3.55%	-6.83%	24.48%
Inventory	$246.4M	$242.8M	$257.0M
Prepaid Expenses
Receivables	$433.6M	$431.0M	$373.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.817B	$2.556B	$2.429B
YoY Change	10.2%	13.22%	13.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$321.6M	$324.9M	$313.7M
YoY Change	-1.02%	18.9%	20.14%
Goodwill		$350.4M
YoY Change		10.58%
Intangibles		$239.1M
YoY Change		8.62%
Long-Term Investments
YoY Change
Other Assets	$151.4M	$112.0M	$111.4M
YoY Change	35.18%	11.79%	60.55%
Total Long-Term Assets	$1.058B	$1.026B	$996.2M
YoY Change	3.06%	12.74%	15.89%
TOTAL ASSETS
Total Short-Term Assets	$2.817B	$2.556B	$2.429B
Total Long-Term Assets	$1.058B	$1.026B	$996.2M
Total Assets	$3.875B	$3.583B	$3.425B
YoY Change	8.15%	13.08%	14.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.70M	$64.96M	$62.80M
YoY Change	1.08%	18.71%	4.22%
Accrued Expenses	$60.50M	$56.30M	$42.20M
YoY Change	7.46%	27.09%	6.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$225.2M	$133.3M	$133.8M
YoY Change	68.94%	0.38%	-70.11%
Total Short-Term Liabilities	$580.5M	$487.5M	$492.9M
YoY Change	19.08%	-3.31%	-35.78%
LONG-TERM LIABILITIES
Long-Term Debt	$1.238B	$1.190B	$1.160B
YoY Change	3.99%	13.88%	65.71%
Other Long-Term Liabilities	$141.7M	$41.77M	$134.7M
YoY Change	21.63%	63.44%	306.27%
Total Long-Term Liabilities	$1.379B	$1.332B	$1.295B
YoY Change	5.56%	11.31%	43.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$580.5M	$487.5M	$492.9M
Total Long-Term Liabilities	$1.379B	$1.332B	$1.295B
Total Liabilities	$1.980B	$1.819B	$1.807B
YoY Change	8.82%	6.98%	8.36%
SHAREHOLDERS EQUITY
Retained Earnings		$3.963B
YoY Change		12.81%
Common Stock		$1.272B
YoY Change		9.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$3.478B
YoY Change		9.5%
Treasury Stock Shares		70.43M shares
Shareholders Equity	$1.895B	$1.763B	$1.619B
YoY Change
Total Liabilities & Shareholders Equity	$3.875B	$3.583B	$3.425B
YoY Change	8.15%	13.08%	14.29%

Cashflow Statement

Concept	2014	2013 Q4	2013 Q3
OPERATING ACTIVITIES
Net Income	$431.6M	$141.6M	$98.00M
YoY Change	-4.09%	-19.5%	-1.11%
Depreciation, Depletion And Amortization	$46.39M	$21.50M	$20.50M
YoY Change	21.56%	22.16%	-0.49%
Cash From Operating Activities	$511.6M	$143.3M	$104.8M
YoY Change	5.51%	8.81%	3.46%
INVESTING ACTIVITIES
Capital Expenditures	-$106.2M	-$25.70M	-$31.50M
YoY Change	-10.38%	-18.93%	20.69%
Acquisitions	$27.01M
YoY Change	-34.76%
Other Investing Activities	-$295.8M	-$109.7M	-$99.90M
YoY Change	-14.58%	-420.76%	21.83%
Cash From Investing Activities	-$402.0M	-$135.3M	-$131.4M
YoY Change	-13.5%	-5512.0%	21.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$337.4M
YoY Change	11.89%
Debt Paid & Issued, Net	$239.8M
YoY Change	-72.96%
Cash From Financing Activities	-107.2M	-2.500M	-9.000M
YoY Change	65.98%	-80.92%	-46.75%
NET CHANGE
Cash From Operating Activities	511.6M	143.3M	104.8M
Cash From Investing Activities	-402.0M	-135.3M	-131.4M
Cash From Financing Activities	-107.2M	-2.500M	-9.000M
Net Change In Cash	2.400M	5.500M	-35.60M
YoY Change	-105.4%	-95.46%	49.58%
FREE CASH FLOW
Cash From Operating Activities	$511.6M	$143.3M	$104.8M
Capital Expenditures	-$106.2M	-$25.70M	-$31.50M
Free Cash Flow	$617.8M	$169.0M	$136.3M
YoY Change	2.39%	3.43%	6.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.27
CY2013Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	25436000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	1552000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.12
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.07
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.20
CY2014	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	10634000	USD
CY2012	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	13829000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.25
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.19
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88979000	shares
CY2013	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1575000	USD
CY2012Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-61728000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	22367000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	347036000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1709000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	639000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32274000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	482277000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-348000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-647000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	6972000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9660000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	471103000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	4120000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	9544000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	134000	USD
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013	wat	Percent Of Net Sales To Pharmaceutical Industry PercentOfNetSalesToPharmaceuticalIndustry	0.52	pure
CY2012	wat	Percent Of Net Sales To Pharmaceutical Industry PercentOfNetSalesToPharmaceuticalIndustry	0.53	pure
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	422177000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	64961000	USD
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	12962000	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83147000	shares
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	85132000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	118302000	USD
CY2014	wat	Maximum Percentage Of Net Sales To Individual Customer MaximumPercentageOfNetSalesToIndividualCustomer	0.02	pure
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	433616000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	246430000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	2853736000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	354838000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115406000	USD
CY2014Q4	us-gaap	Assets Assets	3877934000	USD
CY2013Q4	us-gaap	Debt Current DebtCurrent	133346000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	321583000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	232371000	USD
CY2014	dei	Trading Symbol TradingSymbol	WAT
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-84584000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	11843000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-31566000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	31911000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-40239000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	11092000	USD
CY2012	us-gaap	Interest Expense InterestExpense	28073000	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86546000	shares
CY2012	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	11005000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3962893000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3477759000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5879000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	1763173000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	440796000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3582629000	USD
CY2013Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	128056000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	78800000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	430985000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	324932000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239112000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1190000000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	350350000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	111980000	USD
CY2013Q4	us-gaap	Assets Assets	3582629000	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1331924000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1819456000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1270608000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	242800000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2556255000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43305000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19770000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	487532000	USD
CY2013Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	74723000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41765000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156716000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	73569000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84819000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	70427000	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	2055000000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	1362874000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	7023000	USD
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155246000	shares
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	1467357000	USD
CY2014Q4	us-gaap	Shares Issued SharesIssued	156716000	shares
CY2012Q4	us-gaap	Shares Issued SharesIssued	153696000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1281000	shares
CY2014	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-7844000	USD
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85426000	shares
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	450003000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40102000	USD
CY2014	us-gaap	Interest Expense InterestExpense	34191000	USD
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87841000	shares
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	490105000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1346729000	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	642615000	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	1989344000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	549121000	USD
CY2014	us-gaap	Cost Of Services CostOfServices	275792000	USD
CY2014	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	824913000	USD
CY2014	us-gaap	Gross Profit GrossProfit	1164431000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	512707000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107726000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	517908000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	490740000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1312503000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	59120000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	431620000	USD
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84358000	shares
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	4387000	USD
CY2013	us-gaap	Interest Expense InterestExpense	30050000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	517343000	USD
CY2014	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	15456000	USD
CY2013	us-gaap	Gross Profit GrossProfit	1120762000	USD
CY2013	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	783456000	USD
CY2013	us-gaap	Cost Of Services CostOfServices	256735000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	526721000	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	1904218000	USD
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	591715000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1280507000	USD
CY2012	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	563134000	USD
CY2012	us-gaap	Cost Of Services CostOfServices	235954000	USD
CY2012	us-gaap	Gross Profit GrossProfit	1106027000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	477270000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96004000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	511490000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	4208000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	487625000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	461443000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax	2886000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-12205000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	451115000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-464729000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	563000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	60971000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	34332000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	55928000	USD
CY2013	us-gaap	Interest Paid Net InterestPaidNet	29563000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-402030000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1400000	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	73849000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	337444000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	15703000	USD
CY2014	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-174000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-27888000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax	3055000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-27000	USD
CY2012	wat	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax1 OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForSaleOfSecuritiesBeforeTax1	-968000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesBeforeTax	1575000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2037000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	32998000	USD
CY2014	us-gaap	Depreciation Depreciation	46393000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47838000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	511648000	USD
CY2014	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2196153000	USD
CY2014	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1925816000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-107221000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-21016000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18619000	USD
CY2013	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-8666000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-64588000	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	4202000	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	68958000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	301580000	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2972116000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	484876000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3656000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	31708000	USD
CY2013	us-gaap	Depreciation Depreciation	38165000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	41530000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	481035000	USD
CY2013	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2667232000	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2039000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	15842000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2256000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	29183000	USD
CY2012	us-gaap	Depreciation Depreciation	37422000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31409000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	449280000	USD
CY2012	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	104749000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	31016000	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1815988000	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1655359000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-296394000	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	218324000	USD
CY2012	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	497000	USD
CY2012	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-52219000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	15126000	USD
CY2014	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	1563000	USD
CY2014	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	4718000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	16481000	USD
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	28869000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	295878000	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	10568000	USD
CY2012	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-4186000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-66535000	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	10694000	USD
CY2014	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	1583000	USD
CY2013	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	169000	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	59446000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35233000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	97045000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11389000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5033000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11467000	USD
CY2012	us-gaap	Interest Paid Net InterestPaidNet	28305000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	383990000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29435000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15984000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5784000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14409000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13687000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	9566000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2287000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-28127000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	8512000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7684000	USD
CY2013	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	118450000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	41395000	USD
CY2014	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	91122000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27008000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	239776000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	886644000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1032209000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	1226578000	USD
CY2011Q4	us-gaap	Shares Issued SharesIssued	152757000	shares
CY2013Q4	us-gaap	Shares Issued SharesIssued	155246000	shares
CY2014	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	54000	shares
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	58000	shares
CY2013	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	211000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1185000	shares
CY2012	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	66000	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	630000	shares
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4661000	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4817000	USD
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	5028000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24208000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	64141000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	68821000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	10568000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	15842000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	15703000	USD
CY2012	wat	Adjustments To Additional Paid In Capital Increase In Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInValuationAllowance	2354000	USD
CY2013	wat	Adjustments To Additional Paid In Capital Increase In Valuation Allowance AdjustmentsToAdditionalPaidInCapitalIncreaseInValuationAllowance	892000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	28471000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31211000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32349000	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	295878000	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	301580000	USD
CY2014	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	337444000	USD
CY2014	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5000000	USD
CY2014	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (“Waters</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” or the “Company”) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an ana</font><font style="font-family:Times New Roman;font-size:10pt;">lytical instrument manufacturer that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) </font><font style="font-family:Times New Roman;font-size:10pt;">technology</font><font style="font-family:Times New Roman;font-size:10pt;"> systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed together (“LC-MS”) and sold as </font><font style="font-family:Times New Roman;font-size:10pt;">integrated </font><font style="font-family:Times New Roman;font-size:10pt;">instrument systems using a common software platform</font><font style="font-family:Times New Roman;font-size:10pt;">. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease process</font><font style="font-family:Times New Roman;font-size:10pt;">es (known as “proteomics”), nutritional</font><font style="font-family:Times New Roman;font-size:10pt;"> safety analysis and environmental testing. LC-MS instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine</font><font style="font-family:Times New Roman;font-size:10pt;"> a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (“TA</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">”), the Company primarily designs, manufactures, sells and services thermal analysis, </font><font style="font-family:Times New Roman;font-size:10pt;">rheometry</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">calorimetry</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments, which are used in predicting the suitability</font><font style="font-family:Times New Roman;font-size:10pt;"> and stability</font><font style="font-family:Times New Roman;font-size:10pt;"> of fine chemicals, </font><font style="font-family:Times New Roman;font-size:10pt;">pharmaceuticals, water, </font><font style="font-family:Times New Roman;font-size:10pt;">polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments</font><font style="font-family:Times New Roman;font-size:10pt;">, as well as other </font><font style="font-family:Times New Roman;font-size:10pt;">suppliers</font><font style="font-family:Times New Roman;font-size:10pt;">' instruments,</font><font style="font-family:Times New Roman;font-size:10pt;"> and are typically purchased by customers as part of the instrument system.</font></p>
CY2014	wat	Consolidated Entities ConsolidatedEntities	The Company consolidates entities in which it owns or controls fifty percent or more of the voting shares.
CY2014	us-gaap	Foreign Currency Transactions Description ForeignCurrencyTransactionsDescription	Gains and losses from foreign currency transactions are included in net income in the consolidated statements of operations and were not material for the years presented.
CY2012	us-gaap	Foreign Currency Transactions Description ForeignCurrencyTransactionsDescription	Gains and losses from foreign currency transactions are included in net income in the consolidated statements of operations and were not material for the years presented.
CY2014	us-gaap	Additional Cash And Cash Equivalent Related Text AdditionalCashAndCashEquivalentRelatedText	Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, primarily in bank deposits, U.S. and U.K. treasury bill money market funds and commercial paper.
CY2014	us-gaap	Accounts Receivable Additional Narrative Disclosure AccountsReceivableAdditionalNarrativeDisclosure	Past due balances over 90 days and over a specified amount are reviewed individually for collectibility.
CY2011Q4	wat	Allowances For Doubtful Accounts And Sales Returns AllowancesForDoubtfulAccountsAndSalesReturns	8584000	USD
CY2013	wat	Additions To Allowance For Doubtful Accounts And Sales Returns AdditionsToAllowanceForDoubtfulAccountsAndSalesReturns	4386000	USD
CY2013	wat	Deductions From Allowance For Doubtful Accounts And Sales Returns DeductionsFromAllowanceForDoubtfulAccountsAndSalesReturns	-5569000	USD
CY2013Q4	wat	Allowances For Doubtful Accounts And Sales Returns AllowancesForDoubtfulAccountsAndSalesReturns	7057000	USD
CY2014Q4	wat	Allowances For Doubtful Accounts And Sales Returns AllowancesForDoubtfulAccountsAndSalesReturns	7179000	USD
CY2013Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	929000	USD
CY2013Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	88000	USD
CY2014	us-gaap	Description Of Foreign Currency Derivative Activities DescriptionOfForeignCurrencyDerivativeActivities	The periods of these forward contracts typically range from one to three months and have varying notional amounts, which are intended to be consistent with changes in the underlying exposures.
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	123000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	651000	USD
CY2014Q4	wat	Potential Payments Under Licensing Arrangements PotentialPaymentsUnderLicensingArrangements	15000000	USD
CY2013Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	62851000	USD
CY2013Q4	wat	Waters Restoration Plan Assets WatersRestorationPlanAssets	31203000	USD
CY2013Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	88000	USD
CY2013Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1494823000	USD
CY2014	us-gaap	Cost Method Investments Additional Information CostMethodInvestmentsAdditionalInformation	The Company accounts for its investments that represent less than twenty percent ownership, and for which the Company does not have significant influence, using the accounting standards for investments in debt and equity securities. Investments for which the Company does not have the ability to exercise significant influence, and for which there is not a readily determinable market value, are accounted for under the cost method of accounting. The Company periodically evaluates the carrying value of its investments accounted for under the cost method of accounting and carries them at the lower of cost or estimated net realizable value.
CY2014	us-gaap	Equity Method Investment Additional Information EquityMethodInvestmentAdditionalInformation	For investments in which the Company owns or controls between twenty and forty-nine percent of the voting shares, or over which it exerts significant influence over operating and financial policies, the equity method of accounting is used. The Company’s share of net income or losses of equity investments is included in the consolidated statements of operations and was not material in any period presented.
CY2012	us-gaap	Equity Method Investment Additional Information EquityMethodInvestmentAdditionalInformation	The Company’s share of net income or losses of equity investments is included in the consolidated statements of operations and was not material in any period presented.
CY2013	us-gaap	Equity Method Investment Additional Information EquityMethodInvestmentAdditionalInformation	The Company’s share of net income or losses of equity investments is included in the consolidated statements of operations and was not material in any period presented.
CY2014Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	29000000	USD
CY2014Q4	wat	Waters Restoration Plan Assets WatersRestorationPlanAssets	33935000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3612000	USD
CY2014Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	4000000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	USD
CY2013	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-7857000	USD
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13258000	USD
CY2012	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	7212000	USD
CY2012	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	-8117000	USD
CY2012	us-gaap	Advertising Expense AdvertisingExpense	13000000	USD
CY2014Q4	wat	Cash Equivalents And Investments Amortized Cost Basis CashEquivalentsAndInvestmentsAmortizedCostBasis	1700666000	USD
CY2014Q4	wat	Cash Equivalents And Investments Gross Unrealized Gains CashEquivalentsAndInvestmentsGrossUnrealizedGains	441000	USD
CY2014Q4	wat	Cash Equivalents And Investments Gross Unrealized Losses CashEquivalentsAndInvestmentsGrossUnrealizedLosses	-845000	USD
CY2014Q4	wat	Cash Equivalents And Investments Fair Value CashEquivalentsAndInvestmentsFairValue	1700262000	USD
CY2013Q4	wat	Cash Equivalents And Investments Amortized Cost Basis CashEquivalentsAndInvestmentsAmortizedCostBasis	1399712000	USD
CY2013Q4	wat	Cash Equivalents And Investments Fair Value CashEquivalentsAndInvestmentsFairValue	1399840000	USD
CY2013Q4	wat	Cash Equivalents And Investments Gross Unrealized Losses CashEquivalentsAndInvestmentsGrossUnrealizedLosses	-243000	USD
CY2013Q4	wat	Cash Equivalents And Investments Gross Unrealized Gains CashEquivalentsAndInvestmentsGrossUnrealizedGains	371000	USD
CY2012	us-gaap	Property Plant And Equipment Income Statement Disclosures PropertyPlantAndEquipmentIncomeStatementDisclosures	Gains on disposal were $1 million during the year ended December 31, 2014 and were immaterial for both 2013 and 2012.
CY2014Q4	wat	Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue	872872000	USD
CY2014Q4	wat	Cash Equivalents And Investments Debt Maturities Rolling Year Two And Beyone CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoAndBeyone	763003000	USD
CY2014Q4	wat	Debt Securities DebtSecurities	1635875000	USD
CY2013Q4	wat	Debt Securities DebtSecurities	1325643000	USD
CY2013Q4	wat	Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue	1011459000	USD
CY2013Q4	wat	Cash Equivalents And Investments Debt Maturities Rolling Year Two And Beyone CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoAndBeyone	314184000	USD
CY2012Q4	wat	Derivative Notional Amount1 DerivativeNotionalAmount1	134000000	USD
CY2014	wat	Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	174000	USD
CY2012	wat	Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	1716000	USD
CY2012	wat	Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	4186000	USD
CY2012	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	5902000	USD
CY2014	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	8148000	USD
CY2013	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	8466000	USD
CY2014Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3336000	USD
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	574114000	USD
CY2013Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	561485000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	322373000	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	3000000	USD
CY2013Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	151000000	USD
CY2014	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	-7000000	USD
CY2013	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	35000000	USD
CY2014	wat	Intangible Assets Gross Foreign Currency Translation Adjustments IntangibleAssetsGrossForeignCurrencyTranslationAdjustments	-48000000	USD
CY2014	wat	Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments	-28000000	USD
CY2014	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P8Y
CY2013	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P8Y
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	50000000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-109240000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-96461000	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-102858000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-5863000	USD
CY2013	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-702000	USD
CY2012	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	39840000	USD
CY2014	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	3791000	USD
CY2013	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	5142000	USD
CY2012	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	5599000	USD
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	32258000	USD
CY2013	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	35662000	USD
CY2012	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-19257000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	171759000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	171537000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	170669000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2464000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3342000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3639000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	50000000	USD
CY2014	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	pure
CY2014Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1465243000	USD
CY2013Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1323346000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	57537000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	39933000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	78401000	USD
CY2014	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	23071000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-7764000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2823000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1583000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	169000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-52219000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-6035000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-36410000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-30552000	USD
CY2013Q1	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-30552000	USD
CY2012	wat	Percentage Point Change In Effective Tax Rate Relating To Infrequent Income Tax Items PercentagePointChangeInEffectiveTaxRateRelatingToInfrequentIncomeTaxItems	-8.6	pure
CY2013	wat	Percentage Point Change In Effective Tax Rate Relating To Infrequent Income Tax Items PercentagePointChangeInEffectiveTaxRateRelatingToInfrequentIncomeTaxItems	-6.9	pure
CY2014Q4	wat	Deferred Tax Assets Net Operating Loss Carryforwards And Credits DeferredTaxAssetsNetOperatingLossCarryforwardsAndCredits	102810000	USD
CY2013Q4	wat	Deferred Tax Assets Net Operating Loss Carryforwards And Credits DeferredTaxAssetsNetOperatingLossCarryforwardsAndCredits	116567000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11979000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7163000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	18702000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22684000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	5819000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	3832000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4104000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	3651000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9368000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	23268000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	18097000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15289000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	205180000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	217845000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82550000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94952000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	122630000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	122893000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	16253000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	18012000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	8765000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3798000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	43112000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	40650000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	79518000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	82243000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	34301000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	25391000	USD
CY2014Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	-3000000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	18094000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	18840000	USD
CY2014Q4	wat	Deferred Taxes Valuation Allowance Net Operating Loss Carryforwards And Credits DeferredTaxesValuationAllowanceNetOperatingLossCarryforwardsAndCredits	78000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	36691000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	61920000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	-1096000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	-17997000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	-579000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	-18067000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	31423000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	69466000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	73199000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	64390000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24716000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19596000	USD
CY2014	wat	Other Changes In Uncertain Tax Benefits OtherChangesInUncertainTaxBenefits	-5120000	USD
CY2013	wat	Other Changes In Uncertain Tax Benefits OtherChangesInUncertainTaxBenefits	-4395000	USD
CY2012	wat	Other Changes In Uncertain Tax Benefits OtherChangesInUncertainTaxBenefits	-3184000	USD
CY2014Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	-5000000	USD
CY2013	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	4000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-5625000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-35279000	USD
CY2014	wat	Purchase Price Calculation For Shares Of Stock Under Employee Stock Purchase Plan PurchasePriceCalculationForSharesOfStockUnderEmployeeStockPurchasePlan	The purchase price for each share of stock is the lesser of 90% of the market price on the first day of the plan period or 100% of the market price on the last day of the plan period.
CY2014Q4	wat	Maximum Contribution Allowed Under Employee Stock Purchase Plan As Of Employees Earnings MaximumContributionAllowedUnderEmployeeStockPurchasePlanAsOfEmployeesEarnings	0.15	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	63000000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	64000000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31000000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	98000000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	98000000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	82.67
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	21945000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	17464000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	12760000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6528000	USD
CY2014Q4	wat	Future Minimum Rents Payable In Five Years And Thereafter FutureMinimumRentsPayableInFiveYearsAndThereafter	17473000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30000000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30000000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30000000	USD
CY2014	wat	Future Minimum License Fees Payable FutureMinimumLicenseFeesPayable	Future minimum license fees payable under existing license agreements as of December 31, 2014 are immaterial for the years ended December 31, 2015 and thereafter.
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4200000	shares
CY2014Q4	wat	Total Number Of Shares Purchased Under Employee Stock Purchase Plan TotalNumberOfSharesPurchasedUnderEmployeeStockPurchasePlan	1200000	shares
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2200000	shares
CY2012Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2900000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3200000	shares
CY2014	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1000000	USD
CY2014	wat	Plan Period Employee Stock Purchase Plan In Months PlanPeriodEmployeeStockPurchasePlanInMonths	3	pure
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	60.88
CY2012Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	54.00
CY2013	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1000000	USD
CY2012	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1000000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y10M
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31708000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32998000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29183000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	569000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	428000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	699000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.266	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.248	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.265	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.010	pure
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	112.56
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	97.74
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	32.61
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.37
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	86.55
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.97
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3917000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-21000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3280000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.08
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	88.02
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	82.85
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	58.12
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1655000	shares
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	70.03
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	793000	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1100000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1120000	shares
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1138000	shares
CY2014	us-gaap	Defined Benefit Plan Alternative Method Used To Amortize Net Gains And Losses DefinedBenefitPlanAlternativeMethodUsedToAmortizeNetGainsAndLosses	amortize cumulative actuarial gains and losses in excess of 10% of the larger of the market-related value of plan assets and the projected benefit obligation over the expected future service of active participants.
CY2014Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	202981000	USD
CY2013Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	175952000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	8935000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	8965000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	10499000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	10855000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	11642000	USD
CY2014Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	73887000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	430338000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	174568000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	255770000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	70302000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.83
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84977000	shares
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.82
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85873000	shares
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	481801000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	201853000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	279948000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131930000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26977000	USD
CY2014Q2	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2646000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	118395000	USD
CY2014	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2014	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2013	wat	Percent Of Net Sales Derived From Operations Outside United States PercentOfNetSalesDerivedFromOperationsOutsideUnitedStates	0.71	pure
CY2012	wat	Percent Of Net Sales Derived From Operations Outside United States PercentOfNetSalesDerivedFromOperationsOutsideUnitedStates	0.71	pure
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	430508000	USD
CY2014Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	187719000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	242789000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126635000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24746000	USD
CY2014Q1	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2647000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	88761000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	7489000	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1458000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	82730000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	7971000	USD
CY2014Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131916000	USD
CY2014Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28724000	USD
CY2014Q4	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2616000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	172039000	USD
CY2014Q4	us-gaap	Interest Expense InterestExpense	9669000	USD
CY2014Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	2103000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	164473000	USD
CY2014Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13181000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12428000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1700000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	112124000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15595000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	96529000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.14
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84462000	shares
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.13
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85177000	shares
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	493165000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	202222000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	290943000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	122226000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27279000	USD
CY2014Q3	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2725000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	138713000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	9062000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1762000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	131413000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17916000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	113497000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.36
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83663000	shares
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.34
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84401000	shares
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	583870000	USD
CY2014Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	233119000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	350751000	USD
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	151292000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.82
CY2014Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83217000	shares
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.80
CY2014Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84015000	shares
CY2014Q4	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	15456000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	169325000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27743000	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	141582000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.67
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	123062000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24650000	USD
CY2013Q2	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2382000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	112692000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	7580000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1179000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	104716000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15402000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	118660000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25312000	USD
CY2013Q1	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2393000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	109405000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	7185000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1187000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103407000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17652000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	121059000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.41
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86049000	shares
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.39
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87215000	shares
CY2013Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	188329000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	262786000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	89314000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.04
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85482000	shares
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.03
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86576000	shares
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	457317000	USD
CY2013Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	191568000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	265749000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	120563000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23599000	USD
CY2013Q3	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2518000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	119069000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	7358000	USD
CY2013Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	946000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	112657000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14609000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	98048000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.15
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85185000	shares
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.14
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86364000	shares
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	565448000	USD
CY2013Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	228991000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	336457000	USD
CY2013Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	130680000	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26975000	USD
CY2013Q4	wat	Purchased Intangibles Amortization PurchasedIntangiblesAmortization	2625000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	176177000	USD
CY2013Q4	us-gaap	Interest Expense InterestExpense	7927000	USD
CY2013Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	1075000	USD
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85006000	shares
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.65
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86017000	shares
CY2013Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1575000	USD
CY2011Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	10248000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	1505000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	-13907000	USD
CY2012Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	93576000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	484000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	892000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	80974000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	2354000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	94952000	USD

Files In Submission

Name	View Source	Status
0001193125-15-067900-index-headers.html	Edgar Link	pending
0001193125-15-067900-index.html	Edgar Link	pending
0001193125-15-067900.txt	Edgar Link	pending
0001193125-15-067900-xbrl.zip	Edgar Link	pending
d849246d10k.htm	Edgar Link	pending
d849246dex1014.htm	Edgar Link	pending
d849246dex1017.htm	Edgar Link	pending
d849246dex211.htm	Edgar Link	pending
d849246dex231.htm	Edgar Link	pending
d849246dex311.htm	Edgar Link	pending
d849246dex312.htm	Edgar Link	pending
d849246dex321.htm	Edgar Link	pending
d849246dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g849246g64x79.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wat-20141231.xml	Edgar Link	completed
wat-20141231.xsd	Edgar Link	pending
wat-20141231_cal.xml	Edgar Link	unprocessable
wat-20141231_def.xml	Edgar Link	unprocessable
wat-20141231_lab.xml	Edgar Link	unprocessable
wat-20141231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WAT
WATERS CORP /DE/ Stock $wat

2014 Form 10-K Financial Statement

#000119312515067900 Filed on February 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WAT WATERS CORP /DE/ Stock $wat

2014 Form 10-K Financial Statement

#000119312515067900 Filed on February 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WAT
WATERS CORP /DE/ Stock $wat